Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-12-27
1998-10-06
Eisenschenk, Frank C.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303873, 435183, 435220, C07K 900
Patent
active
058177710
ABSTRACT:
A chimeric compound that contains a cell-specific ligand linked to a pore-forming agent capable of lysing a cell.
REFERENCES:
patent: 4867973 (1989-09-01), Goers et al.
patent: 4975278 (1990-12-01), Senter et al.
Bayley, H., "Novel Biomaterials: Genetically Engineered Pores", 1990, Dept. of Energy Grant No. DE-FG02-90R20018, Worcester Found. for Exptl. Biol..
Walker et al., 1994, Protein Eng.,7:91.
Amato, Science, 1992, Feb. 7, 1992, 255:684.
Tobkes et al., Biochem., 24:1915, 1985, Secondary . . . Protein.
Hird et al., Cancer & Genes, 1990, pp. 183-189, Immunotherapy . . . Antobodies.
Osband et al., Immunol. Today, 1:193, 1990, Problems . . . immunotherapy.
Harris, et al.,Tibled, 11:42, 1993, Therapeutic . . . Age.
Thelesstam et al., Toxicon, 26:51; 1998, Staphylococcal . . . Advances.
Pastan et al., Cell, 47:671, 1986, Immunotoxins.
Chounick et al., Cancer. Res., 51:465, 1991, A Recombinant . . . Immunotoxin.
Gray et al., Inf. Immun., 1984, Primary . . . Wood 46, 46:615.
Bayley Hagen
Walker Barbara J.
Eisenschenk Frank C.
Worcester Foundation for Experimental Biology
LandOfFree
Cell-targeted lytic pore-forming agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell-targeted lytic pore-forming agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell-targeted lytic pore-forming agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-78459